NeuroMetrix, Inc. (NURO) stock declined over -4.36%, trading at $3.73 on NASDAQ, down from the previous close of $3.90. The stock opened at $3.65, fluctuating between $3.65 and $4.02 in the recent session.
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
Employees | 26 |
Beta | 2.294 |
Sales or Revenue | $5.90M |
5Y Sales Change% | -0.511% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |
NeuroMetrix, Inc. (NASDAQ: NURO) stock price is $3.73 in the last trading session. During the trading session, NURO stock reached the peak price of $4.02 while $3.65 was the lowest point it dropped to. The percentage change in NURO stock occurred in the recent session was -4.36% while the dollar amount for the price change in NURO stock was -$0.17.
The NASDAQ listed NURO is part of Medical - Devices industry that operates in the broader Healthcare sector. NeuroMetrix, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Susan M. Bell R.N.
Senior Vice President of Population Health & Value Based Care
Dr. Xuan Kong Ph.D.
Chief Data Scientist
Dr. Shai N. Gozani M.D., Ph.D.
Founder, Chairman, Chief Executive Officer, Pres & Sec.
Mr. Thomas T. Higgins
Senior Vice President, Chief Financial Officer & Treasurer
NURO's closing price is 40.23% higher than its 52-week low of $2.66 where as its distance from 52-week high of $6.40 is -41.72%.
Number of NURO employees currently stands at 26.
Official Website of NURO is: https://www.neurometrix.com
NURO could be contacted at phone 781 890 9989 and can also be accessed through its website. NURO operates from 4B Gill Street, Woburn, MA 01801, United States.
NURO stock volume for the day was 9.04K shares. The average number of NURO shares traded daily for last 3 months was 15.39K.
The market value of NURO currently stands at $7.56M with its latest stock price at $3.73 and 2.03M of its shares outstanding.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com